Oncology Medications

BESREMi®

(ropeginterferon alfa-2b-njft) Injection

BESREMi® (ropeginterferon alfa-2b-njft) Injection Is Available From Onco360!

BESREMi® is an interferon alfa-2b indicated for the treatment of adults with polycythemia vera.

Dosage and Administration1 

  • Recommended starting dose: 100 mcg by subcutaneous injection every 2 weeks (50 mcg if receiving hydroxyurea). 
  • Increase the dose by 50 mcg every 2 weeks (up to a maximum of 500 mcg) until hematological parameters are stabilized
  • Interrupt or discontinue dosing if certain adverse reactions occur 

Dosage Forms and Strengths

Injection: 500 mcg/mL solution in a single-dose prefilled syringe (NDC 73536-500-01) 

 

For full prescribing information, visit Besremi.com

 

How to Order

e-prescribe

e-Prescribe to Onco360 Specialty Pharmacy,
or NPI# 1437577988 under the retail
tab in your EMR/EHR or standalone
e-prescribing application.

Fax

Download the Oral Rx
Oncology Order Form and
fax it to 877-662-6355.
Oral Order Form

Call

Call 877-662-6633.

 1BESREMi® Prescribing Information: PharmaEssentia Corporation accessed 11/2021. BESREMi® is a trademark/registered trademark of PharmaEssentia © 2021 PharmaEssentia